A small clinical trial has shown that when multiple sclerosis patients received a stem cell transplant alongside their chemotherapy, the majority demonstrated improvements in their quality of life.
A Phase 1 clinical trial has investigated the effect of umbilical cord-derived MSCs on the immune systems of Lupus patients. Although the study was small, positive results were observed 24 weeks post-treatment.
A new study suggests that umbilical cord tissue could one day be used to treat chronic, non-healing diabetic foot ulcers. EpiCord, a thick membrane product produced from umbilical cords, has been studied and tested as a form of wound dressing and healing for the ulcers.
A joint US and Chinese clinical trial has successfully demonstrated dental tissue regrowth using stem cells from baby teeth. The Phase 1 trial suggests a promising solution to injury-caused tooth damage in children with young adult teeth.
Researchers at the Stowers Institute of Medical Research have found another way to expand/multiply blood-forming, adult stem cells from umbilical cord blood. The discovery increases the potential of a single stem cell sample in treating more conditions.
Eight-year-old Hamad, from the United Arab Emirates, was cured of sickle cell disease using his younger brother’s cord blood stem cells. His life changing treatment demonstrates the importance of collecting and storing your child’s umbilical cord blood at birth for potential use in the future.
Acute Myeloid Leukaemia (AML) is a prevalent type of cancer in older adults. It is currently treated with intensive chemotherapy and forms of supportive care that lead to 40-60% of patients experiencing complete remission; eliminating signs of cancer. However, most patients relapse, resulting in a 5-year overall survival rate of about 10%.
